Novel SYBR green-based RT-qPCRs developed for lone star virus detection

NewsGuard 100/100 Score

Announcing a new article publication for Zoonoses journal. Lone Star virus (LSV) is a newly characterized arbovirus with pathogenic potential. However, no detection methods are available to specifically identify and monitor LSV.

Two SYBR green-based RT-qPCRs were developed and validated for the detection and quantification of LSV. Two primer sets were evaluated for reproducibility, specificity, and sensitivity. The primer sets were applied to monitor viral titers in vitro and via surveillance of LSV in collected ticks.

One primer set (LSV-S) was the most specific for LSV when tested against 11 other vector-borne viruses. While less specific, the LSV-M primer set detected <2 copies/μl of the viral genome and <1 copy/μL of the viral genome. Viral replication quantified with either primer set yielded similar viral replication patterns, indicating that both primer sets are sufficient to monitor viral titers in vitro. Plaque assays in human and non-human primate cell lines yielded no replicable plaques and could not be used for comparisons of viral titer quantification. LSV was not detected in the 143 ticks collected from southeast Texas.

The SYBR green-based RT-qPCRs described herein can be utilized for the detection and monitoring of LSV for laboratory and tick surveillance purposes.

Source:
Journal reference:

Burch, M. & Bechelli, J., (2024) Development of a SYBR Green-Based RT-qPCR Assay for the Detection and Quantification of Lone Star Virus. Zoonoses. doi.org/10.15212/ZOONOSES-2023-0037.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New study reveals increased risk of allergic diseases after COVID-19 infection